Photoluminescent oxygen-release microspheres to image the oxygen release process in vivo. (1st October 2020)

• Record Type: Journal Article
• Authors: Guan, Ya; Niu, Hong; Dang, Yu; Gao, Ning; Guan, Jianjun
• Is Part Of: Acta biomaterialia. Volume 115(2020)
• Page Start: 333
• Page End: 342
• Publication Date: 2020-10-01
• Subjects: Ischemic vascular disease -- Oxygen release -- Photoluminescence -- In vivo imaging -- Cell therapy; Biomedical materials -- Periodicals; 610.28
• DOI: 10.1016/j.actbio.2020.08.031
• Languages: English
• ISSNs: 1742-7061

Abstract

Abstract: Cell therapy is a promising strategy to treat ischemic diseases, but the efficacy is limited due to high rate of cell death under low oxygen environment of the ischemic tissues. Sustained release of oxygen to continuously oxygenate the transplanted cells may augment cell survival and improve therapeutic efficacy. We have shown previously that oxygen released from oxygen-release microspheres stimulated cell survival in ischemic tissue [1] . To understand how oxygen is released in vivo and duration of release, it is attractive to image the process of oxygen release. Herein, we have developed photoluminenscent oxygen-release microspheres where the in vivo oxygen release can be non-invasively and real-time monitored by an In Vivo Imaging System (IVIS). In the oxygen-release microspheres, a complex of polyvinylpyrrolidone, H2 O2 and a fluorescent drug hypericin (HYP) was used as core, and poly(N-isopropylacrylamide-co-acrylate-oligolactide-co-hydroxyethyl methacrylate-co-N-acryloxysuccinimide) conjugated with catalase was used as shell. To distinguish fluorescent signal change for different oxygen release kinetics, the microspheres with various release profiles were developed by using the shell with different degradation rates. In vitro, the fluorescent intensity gradually decreased during the 21-day oxygen release period, consistent with oxygen release kinetics. The released oxygen significantly augmented mesenchymal stem cell (MSC) survival under hypoxic condition. In vivo, the oxygen release rate was faster. The fluorescent signal can be detected for 17 days for the microspheres with the slowest oxygen release kinetics. The implanted microspheres did not induce substantial inflammation. The above results demonstrate that the developed microspheres have potential to monitor the in vivo oxygen release. Graphical abstract: Image, graphical abstract